Legal & General Group Plc Acquires 5,566 Shares of Masimo Co. (MASI)

Legal & General Group Plc raised its holdings in shares of Masimo Co. (NASDAQ:MASI) by 15.6% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 41,189 shares of the medical equipment provider’s stock after acquiring an additional 5,566 shares during the period. Legal & General Group Plc owned approximately 0.08% of Masimo worth $3,560,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of MASI. SG Americas Securities LLC raised its position in shares of Masimo by 53.8% during the 2nd quarter. SG Americas Securities LLC now owns 18,256 shares of the medical equipment provider’s stock valued at $1,665,000 after acquiring an additional 6,385 shares during the last quarter. Alps Advisors Inc. raised its position in shares of Masimo by 0.3% during the 2nd quarter. Alps Advisors Inc. now owns 4,997 shares of the medical equipment provider’s stock valued at $456,000 after acquiring an additional 13 shares during the last quarter. Bank of New York Mellon Corp raised its position in shares of Masimo by 18.7% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,009,766 shares of the medical equipment provider’s stock valued at $92,070,000 after acquiring an additional 158,801 shares during the last quarter. Comerica Bank raised its position in shares of Masimo by 1.1% during the 2nd quarter. Comerica Bank now owns 35,346 shares of the medical equipment provider’s stock valued at $3,477,000 after acquiring an additional 395 shares during the last quarter. Finally, BNP Paribas Arbitrage SA raised its position in shares of Masimo by 114.7% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 32,879 shares of the medical equipment provider’s stock valued at $2,998,000 after acquiring an additional 17,565 shares during the last quarter. Institutional investors own 83.69% of the company’s stock.

MASI has been the subject of a number of recent analyst reports. BidaskClub cut shares of Masimo from a “hold” rating to a “sell” rating in a research report on Thursday, December 7th. Zacks Investment Research cut shares of Masimo from a “buy” rating to a “hold” rating in a research report on Tuesday, October 3rd. Finally, Stifel Nicolaus restated a “buy” rating and issued a $108.00 price objective on shares of Masimo in a research report on Friday, November 3rd. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and five have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $97.17.

Shares of Masimo Co. (MASI) opened at $86.34 on Friday. Masimo Co. has a 1 year low of $66.79 and a 1 year high of $104.71. The company has a market cap of $4,530.00, a price-to-earnings ratio of 13.68, a P/E/G ratio of 2.87 and a beta of 0.72.

Masimo (NASDAQ:MASI) last released its quarterly earnings data on Tuesday, October 31st. The medical equipment provider reported $0.70 EPS for the quarter, beating the Zacks’ consensus estimate of $0.53 by $0.17. The business had revenue of $193.69 million during the quarter, compared to analysts’ expectations of $189.01 million. Masimo had a net margin of 45.83% and a return on equity of 22.17%. The firm’s quarterly revenue was up 15.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.52 EPS. equities analysts forecast that Masimo Co. will post 2.95 earnings per share for the current year.

In related news, EVP Yongsam Lee sold 5,900 shares of the company’s stock in a transaction on Friday, December 1st. The shares were sold at an average price of $88.31, for a total value of $521,029.00. Following the completion of the transaction, the executive vice president now directly owns 70,800 shares of the company’s stock, valued at approximately $6,252,348. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Steven Barker sold 10,000 shares of the company’s stock in a transaction on Wednesday, November 1st. The stock was sold at an average price of $90.00, for a total transaction of $900,000.00. Following the completion of the transaction, the director now directly owns 73,249 shares of the company’s stock, valued at $6,592,410. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 53,074 shares of company stock valued at $4,737,245. Company insiders own 16.60% of the company’s stock.

WARNING: This piece was first published by Community Financial News and is the property of of Community Financial News. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be accessed at https://www.com-unik.info/2017/12/24/legal-general-group-plc-acquires-5566-shares-of-masimo-co-masi.html.

Masimo Company Profile

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI).

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

What are top analysts saying about Masimo? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Masimo and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit